BioSpace News Archive

Follica’s platform is designed to induce an “embryonic window” in adult skin via a proprietary form of micro-abrasion that initiates hair follicle neogenesis, the formation of new hair follicles from epithelial stem cells.

Dr James Allison is Regental Professor and Chair of Immunology and Executive Director of Immunotherapy at the MD Anderson Cancer Clinic, University of Texas.

BioLineRx Ltd., a clinical-stage biopharmaceutical company focused on oncology, announced that its Chief Executive Officer, Philip Serlin, will present a company update at the JMP Securities 2019 Life Sciences Conference on Wednesday, June 19, 2019 at 2:00 p.m..

Paragon Genomics, Inc. announced the first availability of its CleanPlex® products for use with sequencers from MGI Tech Co., Ltd. (MGI), a leading producer of high-throughput gene sequencers.

High Time to Pay Attention to Innovation Trends in the Developing Medicinal and Recreational “Cannabusiness”

Bloomberg discussed antibody-drug conjugates (ADC) as effective cancer therapies having the potential to replace traditional chemotherapy. ADCs are essentially a “trojan horse” therapeutics which have several advantages over traditional chemotherapy including less toxicity and higher efficacy due to a more precise targeting of cancer cells compared to non-cancer cells.

Rigel Pharmaceuticals, Inc. announced that it will present data on fostamatinib disodium hexahydrate in two posters at the 24th Congress of the European Hematology Association in Amsterdam, The Netherlands, on June 13-16, 2019.

State of the art e-commerce platform to offer exclusive products for the pet market

Columbia Care Inc. announced that it is launching its Columbia National Credit program (the “CNC Card”) across the United States, following a successful pilot program in New York.

Integrated workflow optimization solution improves staff communication and coordination - reducing costs and improving patient satisfaction